Change in Medivir's Board of Directors
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the company's board member Anette Lindqvist has informed the board of directors that she is leaving her position due to personal reasons. - “We respect Anette's decision and at the same time want to thank her for her meritorious efforts. With her competence and experience, she has been a valuable force in the board's work,” says Uli Hacksell, chairman of Medivir’s board of directors.